Search clinical trials for: LY2603618
Total 29 results
-
Eli Lilly and CompanyCompletedAdvanced CancerUnited Kingdom
-
Eli Lilly and CompanyCompletedOvarian CancerUnited States, Israel, Spain, Korea, Republic of, Australia, Belgium, United Kingdom, Italy
-
Eli Lilly and CompanyCompletedSmall Cell Lung CancerSpain, United States, Germany, Ukraine, France, Greece, Turkey, Netherlands, United Kingdom, Korea, Republic of
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell Lung | Advanced Cancer | Anal Squamous Cell Carcinoma | Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Lung Squamous Cell Carcinoma Stage IVUnited States
-
Dana-Farber Cancer InstituteCompletedAdvanced CancersUnited States
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Ovarian Cancer | Prostate CancerUnited States
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedColorectal Cancer | Metastatic Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Germany
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Taiwan, Italy, Korea, Republic of
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedSepsisUnited States, United Kingdom, France, Slovakia, Switzerland, Australia, Poland, Italy, Chile, Germany, Mexico
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedSepsis | Hematologic Neoplasms | Infection | Hematopoietic Stem Cell TransplantationUnited States
-
Eli Lilly and CompanyCompletedPancreatic NeoplasmsUnited States, Germany, Romania, Netherlands, Italy, Spain
-
Eli Lilly and CompanyCompletedSepsisItaly, United Kingdom, United States, Germany, Spain, Belgium, France, Australia, Czech Republic, Netherlands, Canada, Mexico, New Zealand, Finland, Portugal, Brazil, India, Switzerland
-
Eli Lilly and CompanyCompletedHead and Neck NeoplasmsUnited States, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Childhood Solid NeoplasmUnited States
-
Eli Lilly and CompanyCompletedSevere SepsisUnited States, Belgium, Spain, France, Finland, Germany, Canada, United Kingdom, Puerto Rico
-
Eli Lilly and CompanyCompletedSepsisCanada, Finland, Belgium, Argentina, Chile, Australia, Austria, Brazil, Czech Republic, Denmark, Egypt, France
-
Geoffrey Shapiro, MD, PhDEli Lilly and Company; AstraZenecaCompletedSolid TumorUnited States
-
Eli Lilly and CompanyCompletedSubmassive Pulmonary EmbolismGermany
-
Eli Lilly and CompanyCompletedAdvanced CancerSwitzerland
-
Eli Lilly and CompanyCompleted
-
Dana-Farber Cancer InstituteEli Lilly and CompanyTerminatedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Eli Lilly and CompanyCompletedBreast Cancer | Neoplasm Metastasis | Colorectal NeoplasmsUnited States
-
St. Jude Children's Research HospitalEli Lilly and CompanyActive, not recruitingBrain Cancer | Brain Tumor | Medulloblastoma | Brain Tumor, Recurrent | CNS Tumor | Medulloblastoma Recurrent | CNS Cancer | Medulloblastoma, Non-WNT/Non-SHH | Brain Tumor, Pediatric | CNS Neoplasm | Brain Tumor, Refractory | Medulloblastoma, Non-WNT/Non-SHH, Group 3 | Medulloblastoma, Non-WNT/Non-SHH, Group 4United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States